AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AIM ImmunoTech Inc. Director's Dealing 2015

Jun 10, 2015

Director's Dealing

Opens in your device viewer

Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2015-06-08

Reporting Person: Equels Thomas K. (Director, CFO,Vice Chairman,Secretary)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-08	Options to buy Common Stock	$0.25	J	300000	Acquired	2025-06-08	Common Stock (300000)	Direct

F1: Stock Options issued per the employment agreement.